Macrophages, innate immunity and cancer: balance, tolerance, and diversity

被引:1149
作者
Mantovani, Alberto [1 ,2 ]
Sica, Antonio [1 ,3 ]
机构
[1] Ist Clin Humanitas IRCCS, I-20089 Rozzano, Italy
[2] Univ Milan, Dept Translat Med, Milan, Italy
[3] Univ Piemonte Orientale, DiSCAFF, I-28100 Novara, Italy
关键词
TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; CD4(+) T-CELLS; OVARIAN-CANCER; MYELOID CELLS; SUPPRESSOR-CELLS; INTERFERON-GAMMA; BREAST-CANCER; BEARING MICE; IFN-GAMMA;
D O I
10.1016/j.coi.2010.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Smouldering inflammation is a component of the tumor microenvironment and represents the 7(th) hallmark of cancer. Tumor-associated macrophages (TAM) have served as a paradigm for cancer promoting inflammation. Tumor-associated macrophages orchestrate various aspects of cancer, including: diversion and skewing of adaptive responses; cell growth; angiogenesis; matrix deposition and remodelling; the construction of a metastatic niche and actual metastasis; response to hormones and chemotherapeutic agents. T and B cells or cancer cell-derived signals orchestrate the functional reprogramming of TAM. In general TAM acquire M2-like properties and resemble 'tolerant' macrophages, though there is diversity in pathways and phenotypes in different tumors. TAM can also express antitumor activity. Thus, in response to microenvironmental signals, TAM can exert dual influence on tumor growth and progression.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 72 条
[1]   Pathways connecting inflammation and cancer [J].
Allavena, Paola ;
Garlanda, Cecilia ;
Borrello, Maria Grazia ;
Sica, Antonio ;
Mantovani, Alberto .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :3-10
[2]   The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance [J].
Allavena, Paola ;
Sica, Antonio ;
Garlanda, Cecilia ;
Mantovani, Alberto .
IMMUNOLOGICAL REVIEWS, 2008, 222 :155-161
[3]  
ANDREU P, CANC CELL IN PRESS
[4]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[5]   Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development [J].
Aspord, Caroline ;
Pedroza-Gonzalez, Alexander ;
Gallegos, Mike ;
Tindle, Sasha ;
Burton, Elizabeth C. ;
Su, Dan ;
Marches, Florentina ;
Banchereau, Jacques ;
Palucka, A. Karolina .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05) :1037-1047
[6]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[7]  
Berek J S., 2003, J Clin Oncol, V21, p168s, DOI DOI 10.1200/JCO.2003.01.517
[8]   A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) [J].
Biswas, SK ;
Gangi, L ;
Paul, S ;
Schioppa, T ;
Saccani, A ;
Sironi, M ;
Bottazzi, B ;
Doni, A ;
Vincenzo, B ;
Pasqualini, F ;
Vago, L ;
Nebuloni, M ;
Mantovani, A ;
Sica, A .
BLOOD, 2006, 107 (05) :2112-2122
[9]   REGULATION OF THE MACROPHAGE CONTENT OF NEOPLASMS BY CHEMOATTRACTANTS [J].
BOTTAZZI, B ;
POLENTARUTTI, N ;
ACERO, R ;
BALSARI, A ;
BORASCHI, D ;
GHEZZI, P ;
SALMONA, M ;
MANTOVANI, A .
SCIENCE, 1983, 220 (4593) :210-212
[10]   ANTITUMOR AND IMMUNOMODULATORY ACTIVITY OF INTRAPERITONEAL IFN-GAMMA IN OVARIAN-CARCINOMA PATIENTS WITH MINIMAL RESIDUAL TUMOR AFTER CHEMOTHERAPY [J].
COLOMBO, N ;
PECCATORI, F ;
PAGANIN, C ;
BINI, S ;
BRANDELY, M ;
MANGIONI, C ;
MANTOVANI, A ;
ALLAVENA, P .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (01) :42-46